[Use of the CHADS2 score as a predictor of the risk of mortality in hypertensive patients. The FAPRES study]

Med Clin (Barc). 2016 Jun 3;146(11):478-83. doi: 10.1016/j.medcli.2016.03.015. Epub 2016 Apr 30.
[Article in Spanish]

Abstract

Foundations and aim: The aim of this study is to analyze the CHADS2 score as a marker of the risk of mortality in hypertensive patients, with and without the presence of atrial fibrillation.

Methods: We included 1,003 hypertensive patients≥65 years. Risk factors, and CHADS2 score were recorded among other factors, as well as clinical follow-up of number and type of deaths.

Results: Mean age was 72.8±5.8 years, and 47.5% were men. During follow-up there were 41 deaths, 20 were of cardiovascular origin. Patients with higher CHADS2 had a higher mortality: 1.5% CHADS2=1; 4.7% in CHADS2=2; 9.1% in CHADS2=3, and 7.8% in CHADS2≥4.

Conclusions: The CHADS2 score can be a clinical instrument of easy application to identify hypertensive patients with a high risk of mortality.

Keywords: Cardiovascular mortality; Coagulación arterial; Coagulation; Hipertensión arterial; Hypertension; Mortalidad cardiovascular.

Publication types

  • Multicenter Study
  • Observational Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Atrial Fibrillation / complications
  • Female
  • Follow-Up Studies
  • Humans
  • Hypertension / complications
  • Hypertension / mortality*
  • Male
  • ROC Curve
  • Registries
  • Risk Assessment
  • Risk Factors
  • Severity of Illness Index*